ContraFect Inc. (CFRX) stock declines during premarket session. Here’s what you should know?

DPRO Stock

ContraFect Inc. (NASDAQ: CFRX) stock gained by 5.38% at last close whereas the CFRX stock price plunged by 7.65% during the pre market session, at last check. ContraFect is a pharmaceutical corporation specializing in the research and production of DLAs, such as lysins and amurin peptides, as novel medicinal treatments for life-threatening, antibiotic-resistant infections. CFRX […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.